Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC for Knee Osteoarthritis
NCT04716803Recruiting
- Sponsor
- University of California, San Diego
- Start
- Jul 2020
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow cell concentrate in osteoarthritis (OA), sponsored by University of California, San Diego. Primary endpoint: Patients with at least one severe adverse event at 12 months. Started Jul 2020; status: recruiting.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04716803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716803.